Summary
Paraquat is a bipyridyl compound with no known chronic toxicity or teratogenicity. It is poorly absorbed when inhaled, but causes severe illness when ingested orally, death usually occurring within 2 days of ingestion of 50 mg/kg. At lower doses death may be delayed for several weeks. The toxic compound accumulates in lung tissue where free radicals are formed, lipid peroxidation is induced and nicotinamide adenine dinucleotide phosphate (NADPH) is depleted. This produces diffuse alveolitis followed by extensive pulmonary fibrosis. The most important prognostic indicator is the quantity of paraquat absorbed, as shown by the plasma paraquat concentration. While renal failure will develop in the majority of those patients who eventually die, it may not, if present alone, indicate a fatal outcome. The absence of caustic burns in the upper digestive tract indicates a good prognosis.
Treatment of paraquat poisoning remains ineffective, but Fuller’s earth, activated charcoal and resins may prevent some absorption of the toxin. When tubular necrosis occurs, renal excretion of the compound decreases rapidly. A 3- compartment pharmacokinetic model has been described following ingestion of tracer doses including a ‘deep’ compartment for active pulmonary accumulation. Haemodialysis, haemoperfusion and forced dialysis have been attempted, with no clear improvement in survival rates. Superoxide dismutase, glutathione peroxidase, N-acetylcysteine and other ‘free radical scavengers’ have failed to alter the outcome in poisoned patients. Other theoretical treatments, such as deferoxamine, immunotherapy, NADPH repletion and lung transplantation still require clinical validation.
This is a preview of subscription content, access via your institution.
References
Addo E, Poon-King DB. Leucocyte suppression in the treatment of 72 patients with paraquat poisoning. Lancet 1: 1117–1120, 1986
Akahori F, Oehme FW. Inhibition of collagen synthesis as a treatment of paraquat poisoning. Veterinary and Human Toxicology 25: 321–327, 1983
Baud FJ, Houze P, Bismuth C, Scherrmann JM, Jaeger A, et al. Toxicokinetics of paraquat through the heart-lung block: six cases of acute human poisoning. Journal of Toxicology — Clinical Toxicology 26: 35–50, 1988
Bismuth C, Baud FJ, Garnier R, Muczynski J, Houze P. Paraquat intoxication: biological presentation. Journal de Toxicologie Clinique Expérimentale 8: 211–218, 1988
Bismuth C, Garnier R, Dally S, Fournier PE, Scherrmann JM. Prognosis and treatment of paraquat poisoning: a review of 28 cases. Journal of Toxicology — Clinical Toxicology 19: 461–474, 1982
Bismuth C, Michelson AM, Surugue R. Indications théoriques de l’administration de superoxyde dismutase et de glutathion-peroxydase sous inclusion liposomale dans l’intoxication par le paraquat. Congrès des Centres Anti-Poisons Français, Bordeaux, 1983
Bismuth C, Scherrmann JM, Garnier R, Baud FJ, Pontal PG. Elimination of paraquat. Human Toxicology 6: 63–67, 1987
Brown OR, Heitkamp M, Song C. Niacin reduces paraquat toxicity in rats. Science 212: 1510–1512, 1981
Bus JS, Aust SD, Gibson JE. Lipid peroxidation: a possible mechanism for paraquat toxicity. Research Communications in Chemical Pathology and Pharmacology 11: 31–38, 1975
Cadot R, Descotes J, Cuilleron CY, Grenot C, Evreux JC. Evaluation of active specific immunisation against paraquat toxicity in rats. Veterinary and Human Toxicology 28: 226–229, 1986
Cadot R, Descotes J, Grenot C, Cuilleron CY, Evreux JC. Increased plasma paraquat levels in intoxicated mice following antiparaquat F(ab′) treatment. Journal of Immunopharmacology 7: 467–477, 1985
Chester G, Ward RJ. Occupational exposure and drift hazard during aerial application of paraquat to cotton. Archives of Environmental Contamination and Toxicology 13: 551–563, 1984
Chollet A, Bismuth C, Pham J, Bolo A, Muczinsky J, et al. Hypoxygenation avec hypothermie dans l’intoxication humaine par le paraquat: à propos de 6 cas. Toxicological European Research 5: 71–75, 1983
Conning DM, Fletcher K, Swan AAB. Paraquat and selected tripyridyls. British Medical Bulletin 25: 245–249, 1969
Cooke NKJ, Flenley DC, Matthew H. Paraquat poisoning: serial studies of lung function. Quarterly Journal of Medicine 42: 683–692, 1973
Cramp TP. Failure of N-acetylcysteine to reduce renal damage due to paraquat in rats. Human Toxicology 4: 107, 1985
Dunbar JR, AcufT RV, Deluccia AJ. Co-administration of paraquat and putrescine to rats via miniosmotic pump: effects on lung glutathione antioxidant system and paraquat content. Federation Proceedings 44: 1024, 1985
Dunbar JR, Deluccia AJ, Acuff RV, Ferslew KE. Prolonged intravenous paraquat infusion in the rat: I. Failure of coinfused putrescine to attenuate pulmonary paraquat uptake, paraquat-induced biochemical changes, or lung injury. Toxicology and Applied Pharmacology 2: 207–220, 1988
Editorial. Cyclophosphamide for paraquat poisoning. Lancet 2: 375–376, 1986 Fairshter RD, Rosen SM, Smith WR, Glauser FL, McRae DM, et al. Paraquat poisoning: new aspects of therapy. Quarterly Journal of Medicine 180: 551–565, 1976
Fogt F, Zilker T. Total exclusion from external respiration protects lungs from development of fibrosis after paraquat intoxication. Human Toxicology 8: 465–474, 1989
Frank L. Superoxide dismutase and lung toxicity. Trends in Pharmacological Sciences 14: 124–128, 1983
Frank L, Nerishi K, Sio R, Pascual D. Protection of paraquat-induced lung damage and lethality in adult rats pretreated with clofibrate. Toxicology and Applied Pharmacology 66: 269–277, 1982
Gamier R, Bismuth C. Paraquat. Encyclopédie Médico-Chirurgicale (Paris, France). Intoxications 16048 C 15, 1984
Glass M, Sutherland MW, Forman HJ, Fisher AB. Selenium deficiency potentiates lipid peroxidation in isolated perfused rat lung. Journal of Applied Physiology 619–622, 1985
Guyon F, Bismuth C, Leclerc JP, Dauchy F. Intoxication massive par le paraquat mortelle en moins de 24 h: données toxicologiques et anatomocliniques. Journal Européen de Toxicologie 7, 3: 182–187, 1974
Hampson ECGM, Pond SM. Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning. Medical Toxicology 3: 64–71, 1988
Hart TB. Paraquat: a review of safety in agricultural and horticultural use. Human Toxicology 6: 13–18, 1987
Hawksworth GM, Bennett PN, Davies DS. Kinetics of paraquat elimination in the dog. Toxicology and Applied Pharmacology 57: 139–145, 1981
Jaeger A, Ledig JM, Houze P, Sauder P, Kopferschmitt J, et al. Pulmonary Superoxide dismutase activity in four cases of lethal paraquat poisoning. Human Toxicology 7: 100–101, 1987
Kalmholz S, Veith FJ, Mollenkopf F, Montefusco C, Niehlsen-Cannarella S, et al. Single lung transplantation in paraquat intoxication. New York State Journal of Medicine 84: 81–85, 1984
Kohen R, Chevion M. Paraquat toxicity is enhanced by iron and reduced by desferrioxamine in laboratory mice. Biochemical Pathology 34: 1841–1843, 1985
Maling MM, Saul W, Williams MA, Brown EAB, Gillette JR. Reduced body clearance as the major mechanism of the potentiation of •-adrenergic agonists of paraquat lethality in rats. Toxicology and Applied Pharmacology 43: 57–72, 1978
Matthew H, Logan A, Woodruff MFA, Heard B. Paraquat poisoning: lung transplantation. British Medical Journal 3: 759–763, 1968
Meredith TJ, Vale JA. Treatment of paraquat poisoning in man: methods to prevent absorption. Human Toxicology 6: 49–55, 1987
Nagao M, Takatori T, Wu B, Terazawa K, Gotouda H, et al. Immunotherapy for the treatment of acute paraquat poisoning. Human Toxicology 8: 121–123, 1989
Nokata M, Tanaka T, Tsuchiya K, Yamashita M. Alleviation of paraquat toxicity by Kayexalate* and Kalimate in rats. Acta Pharmacologica Toxicologica 55: 158–160, 1984
Osherrof MR, Schaich KM, Drew RT, Borg DC. Failure of desferrioxamine to modify the toxicity of paraquat in rats. Journal of Free Radicals in Biological Medicine 1: 71–82, 1985
Pasi A. The toxicology of paraquat, diquat and morfanquat, Hans Huber Publishers, Bern, 1978
Proudfoot AT, Stewart MS, Levitt T, Widdop B. Paraquat poisoning: significance of plasma paraquat concentrations. Lancet 2: 330–332, 1979
Redetzki M, Wood C, Grafton W. Vitamin E and paraquat poisoning. Veterinary and Human Toxicology 22: 395–397, 1980
Rose MS, Smith LL, Wyatt I. Evidence for energy-dependent accumulation of paraquat into rat lung. Nature 252: 314–315, 1974
Savy FP, Duval G, Her B, Canu P, Fintelz P. Echec de la chimiothérapie et de la radiothérapie au cours des fibroses pulmonaires dues au paraquat. Annales Françaises d’Anesthésie et de Réanimation 7: 159–161, 1988
Scherrmann JM, Galliot M, Garnier R, Bismuth C. Acute paraquat poisoning: prognostic significance and therapeutical interest of blood assay. Toxicological European Research 5: 141–145, 1983
Scherrman JM, Houze P, Bismuth C, Bourdon R. Prognostic value of plasma and urine paraquat concentration. Human Toxicology 6: 91–93, 1987
Shum S, Hale TW, Habersang R. Reduction of paraquat toxicity by N-acetylcysteine. Veterinary and Human Toxicology 6: 31–36, 1982
Smith LL. The identification of an accumulated system for diamines and polyamines into the lung and its relevance to paraquat toxicity. Archives of Toxicology (Suppl. 5): 1–14, 1982
Smith LL. Mechanism of paraquat toxicity in lung and its relevance to treatment. Human Toxicology 6: 31–36, 1987
Smith LL, Rose MS. Biochemical changes in lungs exposed to paraquat. In Autor AP (Ed.) Biochemical mechanisms of paraquat toxicity, Academic Press, New York, 1977
Talbot AR, Barnes MR. Radiotherapy for the treatment of pulmonary complications of paraquat poisoning. Human Toxicology 7: 325–332, 1988
Toronto Lung Transplant Group. Sequential bilateral lung transplantation for paraquat poisoning: a case report. Journal of Thoracic and Cardiovascular Surgery 89: 734–742, 1985
Vaishampayan A. Strong mutagenic action of a bipyridium herbicide in a N2-fixing blue-green algae. Experientia 40: 1016–1019, 1984
Van Asbeck BS, Hillen FC, Boonen HCM, De Jong Y, Dormans JAMA, et al. Death following paraquat intake in the rat is completely prevented by deferoxamine. Abstract 0111 IIIrd World Congress of the World Federation of Associations of Clinical Toxicology and Poison Control Centres, Brussels, 27–30 August, 1986
Van Asbeck BS, Hillen FC, Sangster B. Continuous intravenous infusion of deferoxamine reduces mortality by paraquat in vitamin E deficient rats. American Review of Respiratory Diseases 139: 769–773, 1989
Vincken W, Huyghens L. Schaedevyl W, Verbeglen D, Come L. Paraquat poisoning and colchicine treatment. Annals of Internal Medicine 95: 391–392, 1981
Williams MV, Webb DB. Paraquat lung: is there a role for radiotherapy? Human Toxicology 6: 75–81, 1987
Wright AF, Green TP, Robson RT, Niewola Z, Wyatt I, et al. Specific polyclonal and monoclonal antibody prevents paraquat accumulation into rat lung slices. Biochemical Pharmacology 36: 1325–1331, 1987
Yamashita M, Naito H, Takagi S. The effectiveness of a cation resin (Kayexalate) as an absorbent of paraquat: experimental and clinical studies. Human Toxicology 6: 89–90, 1987
Yonei S, Noda A, Tachibana A, Akasak S. Mutagenic and cytotoxic effects of oxygen free radicals generated by methyliologen (paraquat) on Escherichia coli with different DNA-repair capacities. Mutation Research 163: 15–22, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bismuth, C., Garnier, R., Baud, F.J. et al. Paraquat Poisoning. Drug-Safety 5, 243–251 (1990). https://doi.org/10.2165/00002018-199005040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199005040-00002
Keywords
- Bismuth
- Paraquat
- Clofibrate
- Deferoxamine
- Human Toxicology